Telomir Pharmaceuticals, Inc. $TELO

By Microcap Ledger desk · CIK 0001971532

Facts as of Oct 11, 2026, 08:10 AM UTC. Built from SEC filings and our own data. Small caps move fast; check the latest filings.

This page is still filling in. We publish more sections as filings are processed.

Snapshot

Exchange: Nasdaq Capital Market
Sector: Pharmaceutical Preparations
Headquarters: Miami, FL
Fiscal year end: December 31
Shares outstanding: 68,774,956 [10-Q 2026-08-13]
as of 2026-08-12

Sources: [10-K 2026-03-17]

Financial health

From XBRL company facts (USD)
Period	Revenue	Net income	Operating cash flow	Cash	Filing
6 months to Jun 2026	—	−$2.71M	−$2.79M	$5.17M	[10-Q 2026-08-13]
FY ended Dec 2025	—	−$10.41M	−$3.69M	$7.29M	[10-K 2026-03-17]
FY ended Dec 2024	—	−$16.53M	−$5.07M	$1.27M	[10-K 2026-03-17]

Quarterly cash burn: −$1.39M
Cash runway Estimate: ~11.1 months

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
Date	Shares outstanding	Filing
2024-11-12	29,609,814	[10-Q 2024-11-12]
2025-02-04	29,762,671	[10-K 2025-02-04]
2025-05-14	29,762,671	[10-Q 2025-05-14]
2025-08-14	32,280,970	[10-Q 2025-08-14]
2025-11-07	34,380,971	[10-Q 2025-11-10]
2026-03-12	34,380,971	[10-K 2026-03-17]
2026-05-14	68,774,956	[10-Q 2026-05-14]
2026-08-12	68,774,956	[10-Q 2026-08-13]

Shelf registration: S-3 filed 2025-02-14; declared effective 2025-02-28 [S-3 2025-02-14]

Listing status

Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-01-12. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

Date	Event	Details	Deadline	Filing
2026-01-12	8-K Item 3.01	Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing	—	[8-K 2026-01-12]

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
Date	Insider	Type	Shares	Price	Filing
2026-04-22	Aminov Erez	other	7,319,710	$1.37	[4 2026-04-24]

Catalysts and calendar

Recent filings and releases
Date	Type	Title
2026-10-06	8-K	Material agreement entered; Unregistered sale of equity; Regulation FD disclosure
2026-09-17	8-K	Regulation FD disclosure
2026-09-16	8-K	Shareholder vote results
2026-09-14	8-K	Regulation FD disclosure
2026-08-14	13G/A	Beneficial ownership report (5%+ holder)
2026-08-13	10-Q	Quarterly report
2026-08-10	8-K	Regulation FD disclosure
2026-07-28	DEF 14A	Proxy statement
2026-06-15	8-K	Regulation FD disclosure
2026-06-08	8-K	Director or officer change
2026-05-20	8-K	Regulation FD disclosure
2026-05-14	10-Q	Quarterly report

Facts as of Oct 11, 2026, 08:10 AM UTC. Small caps move fast; check the latest filings.